http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101232993-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-603 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-703 |
| filingDate | 2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101232993-B1 |
| titleOfInvention | Fatty acid biosynthetic enzyme inhibitor-floglucinol-based compound obtained from the crowd and cancer and obesity prevention and treatment composition comprising the same as an active ingredient |
| abstract | The present invention relates to a fluoroglucinol-based compound for inhibiting fatty acid synthase (FAS) derived from spectators and a composition for preventing and treating cancer and obesity comprising the same as an active ingredient. The present invention relates to a FAS inhibitory compound obtained by using pure separation and purification, and to the prevention and treatment of cancer and obesity containing the same as an active ingredient.n n n n Spectrum, Fatty Acid Biosynthesis (FAS), Cancer, Obesity, Florglucinol Compound, Ethanol Extract |
| priorityDate | 2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.